Duke launches the Center for Precision Health dedicated to advancing patient health with genomic research
The Duke Clinical and Translational Science Institute (CTSI) recently launched the Center for Precision Health (CPH), the result of a collaboration between CTSI and the Precision Genomics Collaboratory which focuses on how genomic research can transform patient health.
Surprise Discovery Reveals Key Factor in Multiple Sclerosis
Researchers at Duke University School of Medicine studying multiple sclerosis made an unexpected discovery that could reshape the understanding of MS treatments.
Using Gene Therapy to Treat Brain Disease
Doug Marchuk and Aravind Asokan have been awarded a three-year $1.9 million grant from the Department of Defense to develop less invasive treatment options for familial cerebral cavernous malformations (CCM).
The Long and the Short of It: New sequencing capabilities in the Sequencing & Genomic Technologies Core Facility
The Sequencing and Genomic Technologies (SGT) core facility has added two new sequencers to the lab: the PacBio Revio long-read sequencer and the Illumina NovaSeq X Plus short-read sequencer.
'OneDukeGen' DNA study involves 150,000 Duke patients with a 'precision health' approach
Duke Health has begun major research to find out why some people stay healthy while others develop diseases. The 6-year study will gather DNA data from 150,000 Duke patients.
Heartfelt Gratitude: Duke Patient Contributes to OneDukeGen Study
A Duke Health transplant patient decided to give back by joining OneDukeGen, the new precision medicine study that will analyze the DNA of 150,000 Duke patients and research study participants.
Metabolites in Motion: Predicting Cardiovascular Events in Diabetic Patients
In a new study published in The Journal of Clinical Investigation, researchers performed metabolomic profiling on three different cohorts of patient samples to see which metabolites might predict long-term major adverse cardiovascular events (MACE) among patients with diabetes.
New Center for Precision Health Aims to Transform Population Health, Patient Care
CTSI has launched the Center for Precision Health (CPH), a collaboration led by Svati Shah that will harness the power of genomic, biomarker, and health data to transform patient care and population health.
New Blood Test Detects a Key Indicator of Parkinson’s Disease
Researchers have developed a blood test that detects Parkinson’s disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens.
New Curriculum Advances Cardiovascular Genetics Education
Andrew Landstrom, MD, PhD, associate professor of pediatrics, is hoping to change that. He helped lead efforts with the American Heart Association (AHA) to develop an educational curriculum that addresses the educational needs of health care providers, including clinicians, researchers, and medical students within the cardiovascular field.